BWA
ANGO icon

Basecamp Wealth Advisors’s AngioDynamics ANGO Stock Holding History

Basecamp Wealth Advisors’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.15K Buy
88
+71
+418% +$808 ﹤0.01% 1489
2026
Q1 		$193 Buy
+17
New +$184 ﹤0.01% 1866

Other funds holding ANGO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
BH
Broadfin Holdings Melville, New York $23.7M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WCM
Weber Capital Management San Francisco, California $118M AUM
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Basecamp Wealth Advisors's ANGO Position: Q2 2026 in Review

Basecamp Wealth Advisors increased its AngioDynamics (ANGO) stake by 418% in Q2 2026, buying an estimated $808 and bringing the position to 88 shares worth $1.15K. The position accounts for ﹤0.01% of the portfolio, ranked #1489.

Basecamp Wealth Advisors first reported a position in ANGO in Q1 2026 and has held it in 2 quarters since. 162 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.

  • Basecamp Wealth Advisors held 88 shares of AngioDynamics worth $1.15K as of Q2 2026.
  • Basecamp Wealth Advisors bought 71 AngioDynamics shares in Q2 2026, an estimated $808.
  • AngioDynamics made up ﹤0.01% of Basecamp Wealth Advisors's portfolio in Q2 2026, its #1489 holding.
  • Basecamp Wealth Advisors first reported a position in AngioDynamics in Q1 2026 and has held it in 2 quarters since.
  • 162 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.

Based on Basecamp Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.